Robert H Howland, MD

Associate Professor of Psychiatry

Areas of Expertise

  • Mood Disorders
  • Anxiety, OCD & Trauma Disorders
  • Telepsychiatry
  • Older Adults
  • Basic & Translational Neuroscience
Robert H Howland, MD
Expertise & Interests Selected Publications Education & Credentials Related News

Expertise & Interests

Research Interests

Neuromodulation therapies in psychiatry; Novel psychopharmacological therapies

Clinical Interests

Clinical psychopharmacology; Adult mood and anxiety disorders; Geriatric psychiatry

Education Interests

Medical student & resident education; Contnuing education for community physicians

Selected Publications

  1. Eken HN, Spotts C, Panny B, Griffo A, Degutis M, Cruz N, Bell E, Do-Nguyen K, Wallace ML, Mathew SJ, Howland RH, Price RB. Improved implicit self-esteem is associated with extended antidepressant effects following a novel synergistic intervention. Mol Psychiatry. 2024; 29(11):3431-3439. PMID: 38755245
  2. Rengasamy M, Mathew S, Howland R, Griffo A, Panny B, Price R. Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial. eBioMedicine. 2024 Jan;99:104902. doi: 10.1016/j.ebiom.2023.104902. PMID: 38141395
  3. Price RB, Spotts C, Panny B, Griffo A, Degutis M, Cruz N, Bell E, Do-Nguyen K, Wallace ML, Mathew SJ, Howland RH. A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: A randomized clinical trial. Am J Psychiatry. 2022; 179:959-968. PMID: 36128684
  4. Price RB, Wallace ML, Mathew SJ, Howland RH. One-year outcomes following intravenous ketamine plus digital training among patients with treatment-resistant depression: A secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023 May 1;6(5):e2312434. PMID: 37155171
  5. Kopelman J, Keller TA, Panny B, Griffo A, Degutis M, Spotts C, Cruz N, Bell E, Do-Nguyen K, Wallace ML, Mathew SJ, Howland RH, Price RB. Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression. Transl Psychiatry. 2023 May 9;13(1):159. PMID: 37160885
  6. Howland RH. Can declinining rates of dementia be explained by the increased and widespread use of psychotropic medications? J Psychosoc Nurs Ment Health Serv. 2016;54(3):25-29. PMID: 26935187.
  7. Howland RH. Methylene blue: The long and winding road from stain to brain: Part 2. J Psychosoc Nurs Ment Health Serv. 2016;54(10):21-26. PMID: 27699422.
  8. Howland RH. Methylene blue: The long and winding road from stain to brain: Part 1. J Psychosoc Nurs Ment Health Serv. 2016;54(9):21-24. PMID: 27576224.
  9. Howland RH. Hey Mister Tambourine Man, play a drug for me: Music as medication. J Psychosoc Nurs Ment Health Serv. 2016;54(12):23-27. PMID: 28001283
  10. Howland RH. Deprescribing to reduce medication use: Will this help your patient? J Psychosoc Nurs Ment Health Serv. 2016;54(11):21-24. PMID: 27805712.
  11. Howland R. Anxiety Disorders: OCD (Core Lecture 2.1-2.38). A Model Psychopharmacology Curriculum for Teachers of Medical Students and Primary Care Clinicians, in association with the Journal of Clinical Psychopharmacology, 6th Edition, 2023.
  12. Glick ID, Orr DG, Balon R, Adler L, Ahmed S, Cohen L, Espejo G, Faden J, Hernandez E, Fukuda A, Howland R, Leifer M, Macaluso M, Markota M, Mattioli M, Olagunju A, Raedler T, Schwasinger-Schmidt TE, Shad M, Zuschlag ZD (Editors). A Model Psychopharmacology Curriculum for Teachers of Medical Students and Primary Care Clinicians, in association with the Journal of Clinical Psychopharmacology, 6th Edition, 2023.
  13. Howland R. GAD & PTSD/Social Anxiety/Phobias/Panic Disorder (Core Lecture 3.1-3.40). A Model Psychopharmacology Curriculum for Teachers of Medical Students and Primary Care Clinicians, in association with the Journal of Clinical Psychopharmacology, 6th Edition, 2023.
  14. Dube B, Howland RH. Hallucinogens (Full Course Lecture 25.1-25.65). A Model Psychopharmacology Curriculum for Teachers of Medical Students and Primary Care Clinicians, in association with the Journal of Clinical Psychopharmacology, 6th Edition, 2023.
  15. Goldberg JF, Howland RH. Evaluating and Managing Side Effects of Psychiatric Medications (Core Lecture 16.1-16.42). A Model Psychopharmacology Curriculum for Teachers of Medical Students and Primary Care Clinicians, in association with the Journal of Clinical Psychopharmacology, 6th Edition, 2023.

Education & Credentials

Education & Training

Education
MD, University of Minnesota, School of Medicine
Residency
General Psychiatry, Western Psychiatric Institute and Clinic of UPMC
Postdoctoral
Clinical Research, University of Pittsburgh School of Medicine

Professional Affiliations

  • Distinguished Life Fellow, American Psychiatric Association
  • Fellow, International Society for Affective Disorders
  • Member, American Association for Geriatric Psychiatry
  • Fellow, American Society of Clinical Psychopharmacology
  • Member, American Medical Association
  • Member, Society of Biological Psychiatry

Selected Honors & Awards

  • Excellence in Patient Experience-Top Physician by Specialty Award, UPMC
  • Distinguished Service Award, Southwestern Pennsylvania Human Services, Inc.
  • Distinguished Life Fellow, American Psychiatric Association
  • Distinguished Fellow, American Psychiatric Association
  • Marie H. Eldredge Award, American Psychiatric Association
  • New Investigator Award, National Institute of Mental Health New Clinical Drug Evaluation Unit

Related News